DocDollars

Seikagaku Corporation

Japan · Reporting entity ID 100000005654

Total reported 2019–2025
$16.1M
#366 of 2,960 reporting companies — 0% of all reported industry payments
$0 in general payments across 0 records, plus $16.1M in research funding across 1,052 records.

How it breaks down

Research funding $16,122,766

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Seikagaku Corporation reported $16.1M to US doctors and teaching hospitals from 2019 to 2025, ranking #366 of 2,960 reporting companies. 100% of that was research funding and 0% general payments such as consulting, speaking, food and travel. 0 general payment records and 1,052 research records were filed.

Common questions about Seikagaku Corporation

How much has Seikagaku Corporation paid US doctors?

Seikagaku Corporation reported $16,122,766 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $0 in general payments, $16,122,766 in research funding.

How does Seikagaku Corporation rank among drug and device companies?

It ranks #366 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Seikagaku Corporation mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.